These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12848973)

  • 41. Affinity of human anti-factor VIII antibodies for functional polystyrene supports.
    Dahri L; Stoltz JF; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Mol Recognit; 1996; 9(5-6):401-6. PubMed ID: 9174917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.
    Lavigne-Lissalde G; Rothschild C; Pouplard C; Lapalud P; Gruel Y; Schved JF; Granier C
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):67-79. PubMed ID: 19172415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of Factor VIII A2 Domain Residues 400-409 to a Factor X-Interactive Site in the Factor Xase Complex.
    Takeyama M; Nogami K; Sasai K; Furukawa S; Shima M
    Thromb Haemost; 2018 May; 118(5):830-841. PubMed ID: 29614522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans.
    Hofbauer CJ; Whelan SF; Hirschler M; Allacher P; Horling FM; Lawo JP; Oldenburg J; Tiede A; Male C; Windyga J; Greinacher A; Knöbl PN; Schrenk G; Koehn J; Scheiflinger F; Reipert BM
    Blood; 2015 Feb; 125(7):1180-8. PubMed ID: 25515962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.
    Batlle J; Gómez E; Rendal E; Torea J; Lourés E; Couselo M; Vila P; Sedano C; Tusell X; Magallón M; Quintana M; González-Boullosa R; López-Fernández MF
    Ann Hematol; 1996 May; 72(5):321-6. PubMed ID: 8645745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor.
    Jacquemin MG; Desqueper BG; Benhida A; Vander Elst L; Hoylaerts MF; Bakkus M; Thielemans K; Arnout J; Peerlinck K; Gilles JG; Vermylen J; Saint-Remy JM
    Blood; 1998 Jul; 92(2):496-506. PubMed ID: 9657749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An introduction to factor VIII inhibitors: the detection and quantitation.
    Kessler CM
    Am J Med; 1991 Nov; 91(5A):1S-5S. PubMed ID: 1746589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomimetic biosensor to distinguish between inhibitory and non-inhibitory factor VIII antibodies.
    Kocot C; Schindler AR; Le Blanc A; Schmalenberg M; Miesbach W; Spannagl M; Luppa PB
    Anal Bioanal Chem; 2015 Jul; 407(19):5685-93. PubMed ID: 25957847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response.
    Ozelo MC; Vidal B; Brown C; Notley C; Hegadorn C; Webster S; Harpell L; Ahlin J; Winterborn A; Handforth J; Arruda VR; Hough C; Lillicrap D
    Blood; 2014 Jun; 123(26):4045-53. PubMed ID: 24829206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-idiotypic antibodies: from regulation to therapy of factor VIII inhibitors.
    Saint-Remy JM; Jacquemin MG; Gilles JG
    Vox Sang; 1999; 77 Suppl 1():21-4. PubMed ID: 10529681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiology of inhibitors to factor VIII in patients with haemophilia A.
    Lacroix-Desmazes S; Misra N; Bayry J; Artaud C; Drayton B; Kaveri SV; Kazatchkine MD
    Haemophilia; 2002 May; 8(3):273-9. PubMed ID: 12010423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous inhibitors of factor VIII: kinetics of inactivation of human and porcine factor VIII.
    Green D; Blanc J; Foiles N
    J Lab Clin Med; 1999 Mar; 133(3):260-4. PubMed ID: 10072258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.
    Kaveri SV
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):55-7. PubMed ID: 19153680
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinicohematologic Profile of Patients With Factor VIII Inhibitors: A Case Series.
    Singh N; Mishra P; Tyagi S; Pati HP; Mahapatra M; Seth T; Saxena R
    Clin Appl Thromb Hemost; 2015 Apr; 21(3):246-50. PubMed ID: 25172870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.
    Parra Lopez R; Nemes L; Jimenez-Yuste V; Rusen L; Cid AR; Charnigo RJ; Baumann JA; Smith L; Korth-Bradley JM; Rendo P
    Thromb Haemost; 2015 Oct; 114(4):676-84. PubMed ID: 26293201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies.
    Matsumoto T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2012 Feb; 107(2):288-301. PubMed ID: 22234708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of immune tolerance induction in hemophilia A.
    Schep SJ; Schutgens REG; Fischer K; Boes ML
    Blood Rev; 2018 Jul; 32(4):326-338. PubMed ID: 29482894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.